Steroid therapy and urinary transforming growth factor-β1 in IgA nephropathy

American Journal of Kidney Diseases

Volumn 38, Issue 6, 2001, Pages 1191-1198

  Haramaki, Reiko ^a   Tamaki, Kiyoshi ^a   Fujisawa, Masahisa ^a   Ikedo, Hirofumi ^a   Haramaki, Nobuya ^a   Okuda, Seiya ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Immunoglobulin A (IgA) nephropathy; Steroid; Transforming growth factor 1 (TGF 1)

Indexed keywords

DILAZEP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN A; PREDNISOLONE; STEROID; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; MONONUCLEAR CELL; PROTEINURIA; STEROID THERAPY;

EID: 0035720114     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.29209     Document Type: Article

References (22)

1. TGF-β 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy
2. Matrix-associated latent TGF-β binding protein in the progressive process in adriamycin-induced nephropathy
3. Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis
4. Transforming growth factor-β regulates production of proteoglycans by mesangial cells
5. Urine transforming growth factor-β activity is related to the degree of scarring in crescentic nephritis in the rabbit
6. Increased excretion of urinary transforming growth factor beta in patients with focal glomerulosclerosis
7. Urinary transforming growth factor-β 1 in membranous glomerulonephritis
8. Transforming growth factor-β 1 in renal allograft recipients
9. Latent high molecular weight complex of transforming growth factor-β 1 from rat platelets and structural characterization
10. Purification and structural analysis of a transforming growth factor-β 1 from rat platelets
11. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: A long-term controlled trial
12. Corticosteroids in IgA nephropathy: A randomised controlled trial
13. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy
14. Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy
15. Sodium bicarbonate treatment reduces renal injury, renal production of transforming growth factor-beta, and urinary transforming growth factor-beta excretion in rats with doxorubicin-induced nephropathy
16. Zymosan-stimulated tumor necrosis factor-alpha production by human monocytes. Down-modulation by phorbol ester
17. Expression and secretion of type beta transforming factor by activated human macrophages
18. Glomerulonephritis in renal allografts: Results of 18 years of transplantations
19. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease
20. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1
21. Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit
22. Transforming growth factor-β 1 regulates production of acute phase proteins